Research Paper Volume 14, Issue 19 pp 7941—7958
ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer
Figure 1. Lasso regression screening survival model variables. (A) Variable coefficient corresponding to the model with different number of variables. (B) 1000 models obtained through ten-fold cross validation. (C) Risk coefficient and P value of corresponding genes in multivariate Cox proportional risk regression model.